146 related articles for article (PubMed ID: 8620919)
1. Peripheral administration of Interleukin-1 Receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat.
Relton JK; Martin D; Thompson RC; Russell DA
Exp Neurol; 1996 Apr; 138(2):206-13. PubMed ID: 8620919
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat.
Loddick SA; Rothwell NJ
J Cereb Blood Flow Metab; 1996 Sep; 16(5):932-40. PubMed ID: 8784237
[TBL] [Abstract][Full Text] [Related]
3. Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat.
Stroemer RP; Rothwell NJ
J Cereb Blood Flow Metab; 1997 Jun; 17(6):597-604. PubMed ID: 9236716
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 receptor antagonist attenuates regional neuronal cell death and cognitive dysfunction after experimental brain injury.
Sanderson KL; Raghupathi R; Saatman KE; Martin D; Miller G; McIntosh TK
J Cereb Blood Flow Metab; 1999 Oct; 19(10):1118-25. PubMed ID: 10532636
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of the novel cerebrovascular-selective calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate on ischemic brain damage after permanent middle cerebral artery occlusion in rats.
Minato H; Honda Y; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1996 Jun; 46(6):567-71. PubMed ID: 8767345
[TBL] [Abstract][Full Text] [Related]
6. Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.
Romanos E; Planas AM; Amaro S; Chamorro A
J Cereb Blood Flow Metab; 2007 Jan; 27(1):14-20. PubMed ID: 16596120
[TBL] [Abstract][Full Text] [Related]
7. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
8. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
9. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
10. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat.
Mulcahy NJ; Ross J; Rothwell NJ; Loddick SA
Br J Pharmacol; 2003 Oct; 140(3):471-6. PubMed ID: 12970087
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist.
Yang GY; Liu XH; Kadoya C; Zhao YJ; Mao Y; Davidson BL; Betz AL
J Cereb Blood Flow Metab; 1998 Aug; 18(8):840-7. PubMed ID: 9701345
[TBL] [Abstract][Full Text] [Related]
12. The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia.
Martin D; Chinookoswong N; Miller G
Exp Neurol; 1994 Dec; 130(2):362-7. PubMed ID: 7867766
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous mast cell degranulation in rats receiving injections of recombinant human interleukin-1 receptor antagonist (rhIL-1ra) and/or its vehicle: possible clinical implications.
Bendele A; Colloton M; Vrkljan M; Morris J; Sabados K
J Lab Clin Med; 1995 Apr; 125(4):493-500. PubMed ID: 7706905
[TBL] [Abstract][Full Text] [Related]
14. [Protective effect of dl-3-n-butylphthalide on ischemic neurological damage and abnormal behavior in rats subjected to focal ischemia].
Liu XG; Feng YP
Yao Xue Xue Bao; 1995 Dec; 30(12):896-903. PubMed ID: 8712015
[TBL] [Abstract][Full Text] [Related]
15. The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal ischemia in the rat.
Bordi F; Pietra C; Ziviani L; Reggiani A
Exp Neurol; 1997 Jun; 145(2 Pt 1):425-33. PubMed ID: 9217078
[TBL] [Abstract][Full Text] [Related]
16. Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice.
Gröger M; Lebesgue D; Pruneau D; Relton J; Kim SW; Nussberger J; Plesnila N
J Cereb Blood Flow Metab; 2005 Aug; 25(8):978-89. PubMed ID: 15815587
[TBL] [Abstract][Full Text] [Related]
17. High-dose methylprednisolone treatment in experimental focal cerebral ischemia.
Slivka AP; Murphy EJ
Exp Neurol; 2001 Jan; 167(1):166-72. PubMed ID: 11161604
[TBL] [Abstract][Full Text] [Related]
18. Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia.
Vakili A; Kataoka H; Plesnila N
J Cereb Blood Flow Metab; 2005 Aug; 25(8):1012-9. PubMed ID: 15744246
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats.
Thiyagarajan M; Kaul CL; Sharma SS
Br J Pharmacol; 2004 Jul; 142(5):899-911. PubMed ID: 15197101
[TBL] [Abstract][Full Text] [Related]
20. Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia.
Vakili A; Hosseinzadeh F; Sadogh T
Brain Res; 2007 Sep; 1170():97-102. PubMed ID: 17698046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
